Significantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparin.
Eriksson
Bengt I
BI
Agnelli
Giancarlo
G
Cohen
Alexander
A
Dahl
Ola
O
Mouret
Patrick
P
Rosencher
Nadia
N
Panfilov
Seva
S
Andersson
Magnus
M
D000284:Administration, Oral; D000925:Anticoagulants / Q000494:pharmacology*; D019644:Arthroplasty, Replacement, Hip; D019645:Arthroplasty, Replacement, Knee; D001384:Azetidines / Q000494:pharmacology*; D001596:Benzylamines; D001803:Blood Transfusion; D004359:Drug Therapy, Combination; D017984:Enoxaparin / Q000494:pharmacology*; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006801:Humans; D016015:Logistic Models; D016017:Odds Ratio; D013997:Time Factors
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D017984:Enoxaparin; C109573:melagatran; C426686:ximelagatran; D005998:Glycine